NASDAQ · SIGA
SIGA Technologies, Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
$3.38▲ 0.90% ($0.03)at close
After hours$3.41▲ 0.89%7:30 PM ET
Market cap
$242.43M
P/E
N/M
EPS (TTM)
-$0.04
Next earnings
Nov 5, 2026
Valuation
Revenue & margin DCF
A cash-flow estimate wouldn't be reliable here
Every projected year produces negative free cash flow, so the model returns a negative enterprise value. A discounted-cash-flow valuation cannot be defended on those inputs, so it is not shown.
- 10-yr revenue CAGR
- 0.8%
- Ending operating margin
- 0.0%
- Discount rate
- 10.2%
USD · TTM ending Jun 30, 2026 · Price used $3.38 · Price Oct 2, 8:00 PM UTC
What each scenario assumes. Click a column to start from it.
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock fell 62.23% over the last year. Revenue declined 70.13% over the trailing twelve months. Operating margin moved from 56.25% to -20.76%. Free cash flow declined 117.22% over the trailing twelve months.
What the market seems to be pricing
The market is reacting to weaker business momentum more than just compressing the valuation multiple. Even if the shares already screen cheap on P/S, investors are still discounting lower future earnings power.
What would invalidate this read
Operating margin stands at -20.76%. Revenue declined 70.13% — this read reverses if that trend stabilizes. Free cash flow fell 117.22% — a return toward positive territory would undermine the deterioration thesis. If margins and cash flow stabilize while the stock stays depressed, the gap shifts from fundamental damage toward pure multiple compression.
Return analysis
Company profile
SIGA Technologies, Inc. is a pharmaceutical company with commercialized products, specializing in the health security and infectious disease sectors across the United States.
Market multiples
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Analyst consensus
1
Buy
0
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Nov 5, 2026
Q3 FY26 · EPS est — · Revenue est —
View
Institutional Sentiment
SIGA Technologies, Inc. · SIGA
From Form 13F filings (managers with $100M+). Filings land up to 45 days after quarter end — read this as positioning context, not live fund flow.